|
Jun 13
|
AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease
|
|
Jun 12
|
Blue-Chip Bonanzas: 3 Industry Leaders Trading at Unbelievable Discounts
|
|
Feb 12
|
Top Stock Reports for AbbVie, Applied Materials & American Express
|
|
Feb 12
|
3 Top Dividend Stocks to Maximize Your Retirement Income
|
|
Feb 12
|
AbbVie Completes Acquisition of ImmunoGen
|
|
Feb 12
|
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
|
|
Feb 11
|
These 17 Words From AbbVie's CEO Explain Why the Stock Is Still a Buy
|
|
Feb 10
|
30 Most Valuable Drug Companies in 2024
|
|
Feb 8
|
AbbVie's VYALEV™ (foslevodopa/foscarbidopa solution) Available for the Treatment of Advanced Parkinson's Disease in Canada
|
|
Feb 7
|
Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets
|
|
Feb 6
|
10 Dividend Stocks That are On Sale 30% or More
|
|
Feb 6
|
Calibr-Skaggs announces expansion of option and license agreement with AbbVie to develop novel cell therapies for solid tumors and autoimmune diseases
|
|
Feb 6
|
Novartis (NVS) to Buy MorphoSys & Add Late-Stage Oncology Drug
|
|
Feb 6
|
7 Dividend Stocks Worth Holding for the Long Haul
|
|
Feb 6
|
2 Magnificent Dividend Growth Stocks to Load Up On Right Now
|
|
Feb 6
|
Is WisdomTree U.S. High Dividend ETF (DHS) a Strong ETF Right Now?
|
|
Jan 16
|
AbbVie (ABBV) Registers a Bigger Fall Than the Market: Important Facts to Note
|
|
Jan 16
|
Q4 Earnings Season Scorecard and Analyst Reports for Apple, AbbVie & Toyota
|
|
Jan 16
|
Better Growth Stock: Abbott vs. AbbVie
|
|
Jan 14
|
Here's the Average Amount Investors Have in Stocks by Age 40 and Which Stocks I Recommend Today
|